Dean et al.: Translation of vascular tissue engineering to pediatric CHD 237 19. Van son JA, Reddy M, Hanley FL. Extracar- diac modification of the Fontan operation without use of prosthetic material. J Thorac Cardiovasc Surg. 1995;110(6):1766-8. 20. Bermudez CA, Dearani JA, Puga FJ, Schaff HV, Warnes CA, O’Leary PW, et al. Late re- sults of the peel operation for replacement of failing extracardiac conduits. Ann Thorac Surg. 2004;77(3):881-7. 21. Jonas RA, Freed MD, Mayer JE, Castaneda AR. Long-term follow-up of patients with synthetic right heart conduits. Circulation. 1985;72(3 Pt 2):1177-83. 22. Homann M, Haehnel JC, Mendler N, Paek SU, Holper K, Meisner H, et al. Reconstruc- tion of the RVOT with valved biological con- duits: 25 years experience with allografts and xenografts. Eur J Cardiothorac Surg. 2000;17(6):624-30. 23. Shin’oka T, Imai Y, Ikada Y. Transplantation of a tissue-engineered pulmonary artery. N Engl J Med. 2001;344(7):532-3. 24. Naito Y, Imai Y, Shin’oka T, Kashiwagi J, Aoki M, Watanabe M, et al. Successful clin- ical application of tissue-engineered graft for extracardiac Fontan operation. J Thorac Car- diovasc Surg. 2003;125(2):419-20. 25. Hibino N, Mcgillicuddy E, Matsumura G, Ichi- hara Y, Naito Y, Breuer C, et al. Late-term results of tissue-engineered vascular grafts in humans. J Thorac Cardiovasc Surg. 2010;139(2):431-6, 436.e1-2. 26. Gui L, Zhao L, Spencer RW, Burghouwt A, Taylor MS, Shalaby SW, et al. Development of novel biodegradable polymer scaffolds for vascular tissue engineering. Tissue Eng Part A. 2011;17(9-10):1191-200. 27. Naito Y, Shinoka T, Duncan D, Hibino N, Solomon D, Cleary M, et al. Vascular tissue engineering: towards the next generation vas- cular grafts. Adv Drug Deliv Rev. 2011;63(4- 5):312-23. 28. Duncan DR, Breuer CK. Challenges in trans- lating vascular tissue engineering to the pe- diatric clinic. Vasc Cell. 2011;3(1):23. 29. He W, Yong T, Teo WE, Ma Z, Ramakrishna S. Fabrication and endothelialization of col- lagen-blended biodegradable polymer nanofibers: potential vascular graft for blood vessel tissue engineering. Tissue Eng. 2005;11(9-10):1574-88. 30. Quint C, Kondo Y, Manson RJ, Lawson JH, Dardik A, Niklason LE. Decellularized tis- sue-engineered blood vessel as an arterial conduit. Proc Natl Acad Sci USA. 2011;108(22):9214-9. 31. Hoenicka M, Lehle K, Jacobs VR, Schmid FX, Birnbaum DE. Properties of the human umbilical vein as a living scaffold for a tis- sue-engineered vessel graft. Tissue Eng. 2007;13(1):219-29. 32. Dahl SL, Kypson AP, Lawson JH, Blum JL, Strader JT, Li Y, et al. Readily available tis- sue-engineered vascular grafts. Sci Transl Med. 2011;3(68):68ra9. 33. Weber B, Emmert MY, Schoenauer R, Brokopp C, Baumgartner L, Hoerstrup SP. Tissue engineering on matrix: future of au- tologous tissue replacement. Semin Im- munopathol. 2011;33(3):307-15. 34. Lerou PH, Daley GQ. Therapeutic potential of embryonic stem cells. Blood Rev. 2005;19(6):321-31. 35. Hibino N, Duncan DR, Nalbandian A, Yi T, Qyang Y, Shinoka T, et al. Evaluation of the use of an induced puripotent stem cell sheet for the construction of tissue-engineered vas- cular grafts. J Thorac Cardiovasc Surg. Forth- coming 2012. 36. Hibino N, Nalbandian A, Devine L, Martinez RS, McGillicuddy E, Yi T, et al. Comparison of human bone marrow mononuclear cell iso- lation methods for creating tissue-engineered vascular grafts: novel filter system versus tra- ditional density centrifugation method. Tis- sue Eng Part C Methods. 2011;17(10):993-8. 37. Villalona GA, Udelsman B, Duncan DR, McGillicuddy E, Sawh-Martinez RF, Hibino N, et al. Cell-seeding techniques in vascular tissue engineering. Tissue Eng Part B Rev. 2010;16(3):341-50. 38. Udelsman B, Hibino N, Villalona GA, McGillicuddy E, Nieponice A, Sakamoto Y, et al. Development of an operator-indepen- dent method for seeding tissue-engineered vascular grafts. Tissue Eng Part C Methods. 2011;17(7):731-6. 39. Brennan MP, Dardik A, Hibino N, Roh JD, Nelson GN, Papademitris X, et al. Tissue-en- gineered vascular grafts demonstrate evi- dence of growth and development when implanted in a juvenile animal model. Ann Surg. 2008;248(3):370-7. 40. Roh JD, Nelson GN, Brennan MP, Mirensky TL, Yi T, Hazlett TF, et al. Small-diameter biodegradable scaffolds for functional vascu- lar tissue engineering in the mouse model. Biomaterials. 2008;29(10):1454-63. 41. Roh JD, Sawh-martinez R, Brennan MP, Jay SM, Devine L, Rao DA, et al. Tissue-engi- neered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling. Proc Natl Acad Sci USA. 2010;107(10):4669-74. 42. Matsumura G, Miyagawa-tomita S, Shin’oka T, Ikada Y, Kurosawa H. First evidence that bone marrow cells contribute to the construc- tion of tissue-engineered vascular autografts in vivo. Circulation. 2003;108(14):1729-34. 43. Hibino N, Yi T, Duncan DR, Dean E, Naito Y, Dardik A, et al. A critical role for macrophages in neovessel formation and the development of stenosis in tissue-engineered vascular grafts. FASEB J. 2011;25(12):4253-63. 44. Bergmann CE, Hoefer IE, Meder B, Roth H, van Royen N, Breit SM, et al. Arteriogenesis depends on circulating monocytes and macrophage accumulation and is severely de- pressed in op/op mice. J Leukoc Biol. 2006;80(1):59-65.